EP2830744B1 - Mikrofluss-filtrationssystem und flussfiltrationsverfahren - Google Patents
Mikrofluss-filtrationssystem und flussfiltrationsverfahren Download PDFInfo
- Publication number
- EP2830744B1 EP2830744B1 EP13712250.3A EP13712250A EP2830744B1 EP 2830744 B1 EP2830744 B1 EP 2830744B1 EP 13712250 A EP13712250 A EP 13712250A EP 2830744 B1 EP2830744 B1 EP 2830744B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- reservoir
- circuitry
- fluid
- flow filtration
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001914 filtration Methods 0.000 title claims description 71
- 239000012530 fluid Substances 0.000 claims description 220
- 239000012528 membrane Substances 0.000 claims description 31
- 239000012466 permeate Substances 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 27
- 238000009295 crossflow filtration Methods 0.000 claims description 25
- 239000012465 retentate Substances 0.000 claims description 14
- 230000003287 optical effect Effects 0.000 claims description 7
- 230000001276 controlling effect Effects 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 230000000704 physical effect Effects 0.000 claims 2
- 239000000523 sample Substances 0.000 description 40
- 230000006399 behavior Effects 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- 230000008569 process Effects 0.000 description 15
- 230000004907 flux Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000011026 diafiltration Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/22—Controlling or regulating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/18—Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/20—Accessories; Auxiliary operations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/14—Pressure control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/10—Specific supply elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/14—Specific spacers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/24—Specific pressurizing or depressurizing means
- B01D2313/243—Pumps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/28—Specific concentration chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/50—Specific extra tanks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/10—Cross-flow filtration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/12—Feed-and-bleed systems
Definitions
- the invention relates to a micro flow filtration system and a flow filtration method for increasing the concentration of a component contained in a fluid sample and/or exchange of the fluid in which a compound is contained.
- the system comprises a circuitry with a micro tangential flow filtration module having a semipermeable membrane capable of separating the fluid sample into a retentate stream containing the compound in the fluid and a permeate stream containing the fluid without the compound upon passage of the fluid sample.
- the fluid circuitry further comprises a reservoir integrated into the fluid circuitry, a pump and a plurality of conduits connecting the elements to the circuitry.
- the system further comprises at least one pressure sensors and a flow pressure regulator within the fluid circuitry.
- the semipermeable membrane of such filtration systems can be located in a normal orientation to the flow direction within a flow channel in a way that the membrane covers the complete diameter of the flow channel which is characterized as a normal flow filtration or dead-end filtration, or the membrane surface can be located essentially parallel to the flow direction of the liquid sample which is known as tangential flow filtration system (TFF-system) or cross-flow filtration system.
- TMF-system tangential flow filtration system
- cross-flow filtration system cross-flow filtration system
- Tangential flow filtration systems have the advantage that due to the direction of the flow of the fluid sample, which is essentially parallel to the membrane surface, an automatic sweeping and cleansing takes place so that higher fluxes and higher throughputs can often be attained with such systems in relation to corresponding normal flow filtration systems. Further, a large fraction of sample flows continuously over the membrane surface so that a clogging and fouling is discouraged in such systems. With respect to these and other advantages tangential flow filtration systems are often used in industrial and/or biotechnological processes.
- the components of the solution that are smaller than the pore size of the membrane flow through the membrane as a permeate stream while larger components are retained in a retentate stream.
- the retentate stream is recirculated in the flow circuitry and is pumped across the membrane again in a continuous fashion.
- TFF-systems are used to significantly reduce the volume of the sample solution as a permeate stream is withdrawn from the system. So, the sample solution becomes concentrated when the system is driven in a concentration mode.
- EP 0 995 483 shows a TFF-system in which an reservoir located outside the filtration circuitry is in fluid connection with the circuitry such that fluid flows from the outside reservoir to a smaller reservoir in the circuitry. On the other side, the permeate stream of the filter is directed to the outside reservoir such that the outside reservoir is filled with the permeate.
- an exchange buffer solution typically but not obligatory not containing the component to be separated is added to the system so that one component is withdrawn as permeate stream and exchanged by another component, i.e. by the exchange buffer solution, so that in the end, for example, one buffer is exchanged by another buffer.
- a diafiltration mode and a concentration mode can be combined in systems using special control strategies.
- Tangential flow filtration systems are often used in the production of substances useful for biotechnological, chemical and therapeutical or diagnostic applications. In such industrial scale production processes the filtration process is usually used to increase the concentration of active ingredients.
- WO 2007/110203 discloses an automated crossflow filtration system in small scale for separation a component of interest from ore or more other components in at most 50 milliliter of a solution.
- the solution containing the components to be concentrated for example proteins, particles, aggregates, ions, bacteria, viruses, nucleic acids, saccharides or the like, is located in a reservoir that is integrated into the fluid circuitry.
- the reservoir has a large volume in comparison to the volume of the rest of the circuitry.
- the reservoir is approximately 0.1 to 5 I.
- An example of such a system with a reservoir of 500 milliliter is disclosed in US 2001/37966 .
- the volume of the reservoir is respectively larger.
- the concentration curve of such a system having a large reservoir integrated in the circuitry has an exponential form.
- the concentration curve shows the concentration over the process time and is quite flat at the beginning of the process when only a small amount of fluid relative to the overall fluid volume is withdrawn as a permeate stream.
- a relatively small volume in the fluidic system with respect to the start volume leads to a high increase of the concentration curve.
- This behavior of the concentration curve is advantageous because the concentration in the solution is relatively small over a wide range of process time. So, during this period the risk of clogging or fouling is reduced in the process.
- the large volume of the reservoir compared with the volume of the rest of the circuitry has the disadvantage that the minimal working volume of the circuitry increases. Due to the large internal surface of the reservoir a non-negligible volume of fluid remains in the reservoir, even if it is almost depleted. The reason for this fact is the adhesion force between fluid and reservoir surface. This leads to a reduction of the maximum concentration factor because the minimum working volume of the complete circuitry increases. Further, the large fluid-air interface in a large reservoir may promote unwanted reactions between components in the fluid and air. This problem appears in both lab-scale and industrial scale systems. The minimal working volume is sometimes also called minimal recirculation volume.
- WO 2006/26253 A2 discloses a fluid circuitry with a reservoir integrated into the circuitry.
- the circuitry described is of a lab-scale system to acquire data useful for larger scale development qualification and validation of systems.
- a special tank for housing the solution is used.
- the tank has an inlet and an outlet at the bottom.
- the disadvantage of this system is an inhomogeneous distribution of the components contained in a fluidic solution. Therefore, it is proposed that the tank comprises a mixing zone with a magnetic stirrer for mixing the fluid thereby creating a more homogeneous sample from which useful data can be acquired.
- Such special tank with a mixer is quite expensive and the complexity of the whole system is increased.
- a magnetic stirrer induces shear stress on fluid components.
- a tangential flow filtration device being able to concentrate a component of a solution by a large concentration factor, even with small fluid sample volumes, preferably with a fluid volume of less than 100 ml. It is an object of the invention to provide an optimized TFF-system being able to provide such a large concentration factor wherein the fluid volume of the reservoir is sufficiently large compared with the minimal working volume of the system. Further, a clogging and fouling in the TFF-module should be avoided over a large time period during the filtration process.
- the problem is solved by a micro flow filtration system for a fluid sample with the features according to claim 1.
- the object is also solved by a flow filtration method according to claim 12.
- the micro tangential flow filtration system according to the invention for increasing the concentration of components contained in a fluid comprises a fluid circuitry and a first fluid reservoir.
- the first reservoir is an external reservoir outside the circuitry but has an unidirectional fluid connection to the circuitry.
- the first reservoir is a discrete element, like a tank. It can also be formed by container, a vessel, a canister or a kind of keg.
- the first reservoir is connected to the circuitry via a connection conduit which is preferably a capillary channel or a tube or the like. Preferably only one fluid connection from the first reservoir to the circuitry exists.
- the connection conduit is designed and arranged in such a manner that it prevents fluid from flowing back from the circuitry into the first reservoir.
- fluid is to be understood as a liquid, preferably a buffer solution or a fluid sample comprising components useful for therapeutic or diagnostic purposes (e.g. proteins). Also a body fluid, for example full blood, can be used as a fluid.
- the fluid circuitry comprises a tangential flow filtration module, a second fluid reservoir integrated in the fluid circuitry, a pump for creating and driving a fluid flow through the fluid circuitry, preferably at least one pressure sensor and also preferably a pressure regulator.
- the circuitry further comprises a plurality of conduits connecting all elements together.
- the second reservoir is included in the circuitry and is preferably designed as a discrete fluidic element, for example a container, a tank or the like.
- the functionality of the second reservoir can also be provided by another structural element of the circuitry so that this structural element fulfills an additional function.
- such element can be a flexible tube having an extended section and an enlarged inner lumen or a tube with an enlarged inner diameter and inner lumen so that a predetermined volume can be stored in the element or the respective amended section of the element. So, this structural element being a tube, for example, performs its original transport function and the additional reservoir function (or storage function) of the reservoir.
- the tangential flow filtration module has a feed inlet, a retentate outlet, a permeate outlet and a semipermeable membrane capable of separating the fluid sample into a retentate stream and a permeate stream upon passage of the fluid sample into the tangential flow filtration module through the feed inlet.
- the TFF-module is a micro flow filtration module having a pore size of the membrane corresponding to a molecular weight cut off of approximately 1 to 1000 kD (kilo Dalton).
- the membrane of the TFF-module has a pore size in the range of approximately 2 ⁇ m to 0.05 ⁇ m, preferably of at most 0.1 ⁇ m. This is also the approximate membrane cut off range.
- the membrane could also be capable for performing an ultrafiltration so that the pore size of the membrane can be arranged of less than 0.1 ⁇ m until approximately a cut off range of 1 kD.
- the second fluid reservoir has a reservoir inlet and a reservoir outlet both are in connection to the circuitry so that a fluid in the circuitry can flow through the reservoir.
- the reservoir can feature an inlet to the first reservoir located outside the fluidic circuitry.
- the pump of the circuitry drives the fluid flow of the fluid sample through the fluid circuitry including the tangential flow filtration module and also through the second reservoir in the circuitry.
- at least two pressure sensors are used for acquiring and detecting data about the fluid sample. These data are usually pressure values for calculating a pressure difference value out of which the viscosity of the fluid contained in the circuitry can be determined.
- a pressure regulator is used for regulating the pressure of the fluid sample in the circuitry, based on the results of these determinations.
- the arrangement of the first reservoir and the fluid circuitry including the second reservoir has the advantage that in the concentration mode a strict limitation between the fluid volume of the first reservoir and the fluid volume of the second reservoir (including the volume of the circuitry) and a strict limitation of the fluid contained therein is possible.
- the concentration of the fluid in the first reservoir and the concentration of the fluid in the circuitry are the same only at the beginning of the filtration process. During the rest of the concentration process the concentration of the fluid in the first reservoir is different from the concentration of the fluid in the circuitry due to the fact that the concentration in the circuitry changes over the process time.
- the concentration of the fluid in the first reservoir is generally known or predetermined.
- the concentration of the fluid in the first reservoir is constant and does not change, especially the concentration is not increased.
- the concentration changes during the process.
- the concentration and the volume in the circuitry is exactly defined as long as the first reservoir is not completely empty.
- connection conduit has preferably a length that prevents an effective diffusion of molecules contained within the fluid from the second reservoir into the first reservoir during the time of the filtration process and/or a diameter which is less than the diameter of the circuitry and/or less than the diameter of the second reservoir.
- a valve or a back-pressure valve can be established in the connection conduit between the first reservoir and the circuitry. It is also possible that the pressure in the circuitry is controlled in such a manner that the pressure in the circuitry is less than the pressure in the first reservoir and/or in the connection conduit.
- the connection conduit is designed as a thin and long tube so that a fluid stream from the circuitry into the first reservoir is reliably prevented.
- connection conduit has a diameter of at most 1 mm, preferably of at most 0,75 mm and particularly preferably of at most 0,5 mm. Such a conduit is advantageous with respect to the prevention of a flowing back of fluid and/or of a diffusion of molecules contained within the fluid from the circuitry into the first reservoir.
- connection conduit has a length of at least 10 mm, preferably of at least 50 mm and particularly preferably of at least 100 mm. It is also preferred that a length of the connection conduit is at least 200 mm, 300 mm or more.
- connection conduit between the external first reservoir and the circuitry has the advantage that the first reservoir which is a discrete element and is preferably designed as a container can be disposable or separable from the circuitry. So, the first reservoir can be separated from the circuitry. This is advantageous with respect to the exchange of the reservoir and its content, with respect to the filling or a possible re-filling of the first reservoir and especially with respect to the cleaning of the reservoir.
- the system according to the invention was developed on basis of the inventive idea that with a large internal reservoir, which is integrated in the fluid circuitry, the minimal recirculation volume of the circuitry increases.
- the concentration curve which shows the concentration over the time during operation of the flow filtration system, shows an exponential behavior which is advantageous due to the reduction of clogging and fouling effects of the membrane of the TFF-module.
- the internal reservoir of the circuitry can be withdrawn and exchanged with an external positioned reservoir. It was realized that this is no appropriate option although the external reservoir has no influence to the minimal working volume of the circuitry. In case of an external positioned reservoir the behavior of the concentration in the flow filtration module is disadvantageous.
- the concentration curve shows linear behavior so that a relatively high increase of the concentration in the module is generated from the beginning of the filtration process. Therefore, the system shows a higher risk to clogging and fouling reducing the permeate flow rate. Further, the viscosity of the fluid sample increases demanding an increase of the system's pressure and complicate the achievement of a constant transmembrane pressure over the whole concentration process.
- the fluid connection between the first reservoir and the circuitry is designed by a connection conduit like a tube, a flexible tube or a fluid channel. So, the fluid flowing from the first reservoir into the circuitry and through the circuitry is not flowing back through or into the first reservoir. Therefore, preferably only one unidirectional connection between the external first reservoir and the circuitry exists.
- the external first reservoir is the main reservoir for the fluid sample to be processed (in a concentration mode).
- concentration of the fluid shows a behavior which corresponds to the combination of the behavior of the two versions of state of the art filtration systems.
- the combined inventive system shows a linear concentration curve until the external reservoir is empty and as long as fluid flows from the first reservoir into the circuitry. If the external reservoir is empty an exponential increase of the concentration starts. So, the exponential phase of the concentration curve can be delayed using the second reservoir. Because the second reservoir is significantly smaller than the first external reservoir, its influence to the minimal recirculation volume or the minimal working volume is very small or negligible. Additionally effects derived from a large fluid-air interface can also be reduced. The external first reservoir does not make a contribution to the recirculation volume of the circuitry, so it can be as large as desired.
- the slope of the concentration curve during the linear phase can be determined and adjusted with respect to the ratio of the external reservoir to the internal reservoir, e. g. the ratio of the volume of the external reservoir to the volume of the circuitry including the internal (second) reservoir.
- the first reservoir has a volume which is at least two times larger than the volume of the circuitry (including the second reservoir). It is further preferred that the volume of the first reservoir is at least five times larger than the volume of the circuitry, further preferably at least ten times larger or particularly preferably at least 15 times larger than the volume of the circuitry. It is also preferred that the first reservoir's volume is at least 50 times larger than the volume of the circuitry. In other embodiments the first reservoir's volume is preferably at least 100 times larger, particularly preferably at least 1000 times larger than the volume of the circuitry. So, a large fluid batch can be handled in the system without increasing the volume of the circuitry and therefore without increasing the minimal working volume of the system. An increase of the minimal working volume of the system leads to a restriction in the maximal concentration rate that can be performed with the system.
- the TFF-system is usually used for fluid and liquid batches of at most 150 ml, preferably of at most 100 ml.
- the system is preferably suitable to perform a purification or concentration of liquid batches of at most 20 ml, also preferably of at most 10 ml. Even smaller fluid volumes of at most 2 ml or 1 ml can also be concentrated.
- the start volume of the concentration process is preferably in the range between 150 ml to 1 ml.
- the first and the second reservoir have a respective volume.
- the volume of the first reservoir is normally in the range of the start fluid volume.
- the system according to the invention can be used for concentrating a component contained in a fluid sample like a protein or a molecule or the like. If the system is used in such concentration mode the first reservoir and the second reservoir both contain the same fluid sample. Optionally further external reservoirs can be added in addition so that one or more components in a solution can be exchanged.
- the volume of the second reservoir is at most 2 ml, preferably at most 1 ml.
- a system with such a dimensioned second reservoir is usually used in a laboratory. Small amounts of a solution can be handled and the influence of the second reservoir to the minimal working volume or minimal recirculation volume is restricted.
- the second reservoir is preferably at most 0.7 ml or particularly preferably at most 0.5 ml.
- a second reservoir of this volume has the advantage that the influence to the minimal working volume is further restricted and fluid batches of 100 ml or less, preferably of at most 20 ml, can be purified so that a maximal concentration rate of at least 10, preferably of at least 40, can be reached.
- the maximal concentration rate can also be preferably at least 100, particularly preferably at least 1000.
- the fluid circuitry comprises an optical measuring device for acquiring data related to the concentration of the components contained in the fluid sample.
- an optical measuring device can be a cuvette or the like combined with a suitable light source, a monochromator or filter equipment and a detection unit for measuring the remaining light after passing the sample.
- the object of the invention is also solved with a flow filtration method having the features of claim 12.
- the method preferably for increasing the concentration of component contained in a fluid sample or for purification uses a tangential flow filtration module which is part of a fluid circuitry of a micro flow filtration system.
- the system also comprises a first reservoir which is connected via a connection conduit with the circuitry in such a manner that a fluid flows unidirectionally from the first reservoir into the circuitry.
- the connection conduit prevents fluid from flowing back from the circuitry into the first reservoir. So, the concentration of the fluid in the first reservoir is constant, in particular during the whole filtration process.
- the first reservoir is filled with a fluid sample.
- the whole circuitry including the second reservoir is then filled with the sample due to the pump of the circuitry starting to work.
- the second reservoir is directly or indirectly (via the circuitry) filled before the rest of the circuitry or the complete circuitry is filled with fluid. If the circuitry does not contain any fluid at the beginning of the filling process, the pump preferably generates an under-pressure so that fluid is sucked into the circuitry and/or into the second reservoir.
- the circuitry can also be filled using other known forces or means.
- the circuitry also comprises a vent to let escape air or gas during the filling process of the empty circuitry. So, air bubbles in the system are avoided so that a processing free of disturbances and/or free of artefacts is possible.
- the fluid sample is driven through the circuitry and passes the TFF-module. Thereby, an amount of fluid is (continually) withdrawn from the circuitry as permeate stream.
- concentration of the component in the fluid sample in the circuitry is thereby increasing.
- concentration of the component in the retentate stream increases while the permeate stream is the purified fluid solution.
- a continuous flow of fluid from the first reservoir to the second reservoir is established until the first reservoir is almost empty. So, as long as enough fluid is contained in the first reservoir to establish a continuous flow of fluid, the amount of fluid withdrawn in the filtration module is substituted by the same amount of fluid from the first reservoir.
- a regulator like a pressure regulator or a valve preferably controls the fluid flow and/or the pressure within the circuitry. The fluid flow is particularly preferable controlled by controlling and/or adjusting the pump of the circuitry.
- the concentration curve of the component shows a linear behavior as long as fluid is contained in the first reservoir.
- the volume of the first reservoir has no influence to the minimal working volume of the circuitry.
- the slope of the concentration curve in the linear phase depends on the volume of the fluidic circuitry and on the flux of the fluid through the filtration module, e. g. it depends on the flux of the permeate stream. Further, the actual concentration is also depending on the start concentration of the components contained in the fluid sample.
- the slope of the concentration curve in the linear phase is adjusted to a low value by the choice of suitable dimensions of the first and of the second reservoir and the volume of the fluidic circuitry and the permeate flow rate so that the concentration increases at the beginning of the filtration process only with a small slope.
- the adjustment is performed as described above.
- the filtration system shows the same behavior as the known filtration systems in the state of the art with an internal reservoir.
- the second reservoir is sufficiently small in relation to the starting volume of the overall system.
- the time-dependent course of the concentration shows an exponential behavior wherein the concentration rate increases exponentially during this exponential phase of the operation. So, there is a high increase of the concentration at the end of the process. Therefore, the inventive system and the inventive method both avoid a clogging and a fouling of the membrane of the filtration module over the longest time period of operation.
- the concentration of the components in the fluid sample is monitored.
- the operation of the system can be stopped due to a predetermined end value, e. g. a concentration increase, an end concentration or an end volume or after a defined time.
- the fluid flow in the circuitry can also be stopped if the concentration increase reaches a designated concentration rate or if a designated targeted sample concentration is reached.
- the pump of the circuitry is stopped then.
- the fluid flow can be stopped if the amount of the fluid sample contained in the circuitry reaches the minimum working volume of the circuitry.
- the minimum working volume or minimum recirculation volume is defined as a minimal volume with which the circuitry can be driven without pumping air into the conduits or the circuitry. So, the minimal working volume is defined as the volume of all conduits in the circuitry connecting the elements in addition to the fluid volume which can be contained in pressure regulator or valve (if present), the at least one pressure sensor (if present), the pump and the tangential flow filtration module plus an amount of fluid which has to be in the conduits of the second reservoir and optionally the volume of the optical measuring device and/or the viscosity measuring device.
- the volume of the second reservoir integrated in the fluid circuitry is taken into account as so far as the second reservoir must contain a suitable volume of fluid so that no air, which is contained in the second reservoir when the fluid amount decreases, is pumped into the connecting conduit.
- This minimal fluid volume to be contained within the second reservoir is the partial volume of the second reservoir to be considered for the determination of the overall minimal working volume of the circuitry.
- the method according to the invention preferably allows an increase in concentration of the components in the solution by a factor of at least two, further preferably at least ten and also further preferably of at least 50.
- the maximal factor of increase in concentration depends on i.e. the start volume of the solution in the first reservoir in relation to the minimal working volume of the circuitry.
- the factor of increase in concentration is preferably at least 100, particularly preferably at least 1000.
- a system having a first reservoir with a fluid volume contained of 150 ml and a minimal working volume of 100 ⁇ l shows a maximum increasing factor in concentration of 1500.
- the volume of the second reservoir in the circuitry is approximately between 1 ml to 0.5 ml.
- the slope of the concentration curve during the essentially linear phase of the concentration process is preferably at most 0.5, further preferably at most 0.2, further preferably at most 0.1, further preferably at most 0.05, further preferably at most 0.02.
- the concentration curve is defined as the concentration over the operation time which is similar to the concentration in relation to the permeate stream or the flux of the filtration module.
- the slope of the concentration curve is similar to the change in concentration over the time.
- the slope of the concentration curve in the linear phase is particularly preferably at most 0.01, further preferably at most 0.005, further preferably at most 0.002, further preferably at most 0.001, further preferably at most 0.0005, further preferably at most 0.0002, particularly preferably at most 0.0001, and further particularly preferably at most 0.00001.
- the unit of the slope of the concentration curve is milligram per milliliter and second.
- the method contains the step of controlling the flow from the first fluid reservoir into the circuitry in such a manner that a predetermined pressure or a predetermined flow in the circuitry is adjusted.
- the flow from the first reservoir can also be controlled in a manner that a predetermined amount of sample fluid is contained in the circuitry.
- the fluid of the first reservoir flows directly into the second reservoir of the circuitry, preferably via a direct-line connection conduit.
- the flow of the fluid from the first reservoir into the circuitry is controlled by a pressure force which results from a pressure difference between fluidic circuitry and the first reservoir.
- the respective amount of fluid is sucked out of the first reservoir into the circuitry. It is preferred that the flow of the fluid from the first reservoir is controlled in such a manner that the volume of the fluid contained in the second reservoir and/or in the circuitry is essentially constant (as long as the first reservoir is filled).
- choosing and adjusting a start volume contained in the first reservoir is performed preferably in such a manner that the ratio of the fluid volume in the circuitry to the start fluid volume in the first reservoir is adjusted. This ratio is predetermined in such manner that the transition zone between the linear behavior of the concentration curve and the exponential behavior of the concentration curve is in a predetermined region.
- the transition from linear behavior to exponential behavior takes place in the end phase of operation, preferably if the amount of the volume of the solution is reduced to at least 50 % of the start volume, preferably to at least 10 % of the start volume, preferably to at least 5 % of the start volume, also preferably to at least 2 % of the start volume.
- the amount of the volume of the solution is reduced to at least 0.5 % of the start volume when the transition from linear behavior to exponential behavior takes place.
- Fig. 1a shows a principal schematic view of a filtration system having a circuitry of which only the pump P and the filtration module F and the reservoir R are shown.
- the reservoir R is integrated in the circuitry.
- the concentration curve shows the concentration over the time in principal. It is clearly shown that the concentration curve has an exponential behavior. After a time of 30 min the concentration increases from a start concentration of 1 mg/ml to an amount of 1.14 mg/ml. After 200 min the concentration reaches a value of 5 mg/ml. At a time of 248 min the concentration reaches an amount of approximately 125 mg/ml. So, the increase of the concentration at the beginning is relatively smooth. Thereby, the risk of clogging and fouling of the membrane is reduced.
- this kind of circuitry has the disadvantage that the volume of the reservoir R has to be considered in the minimal working volume of the circuitry which lets the minimal working volume increase and has the demand to implement a mixer into the reservoir if the formation of concentration gradients in the reservoir during the filtration process has to be avoided. So, the maximum possible concentration factor is limited.
- Fig. 1b shows a filtration system with a circuitry in which the pump P and the filtration module F are integrated.
- the reservoir R is located outside the circuitry and is in fluid connection to the circuitry.
- the fluid flows unidirectional from the reservoir R into the circuitry.
- the volume of the reservoir R does not have to be considered in the minimal working volume. So, the minimal working volume is very low.
- the disadvantage of this system is that the concentration rises linear over the time. At a time of 30 min the concentration is increased from a start concentration of 1 mg/ml to an actual concentration of 19 mg/ml. At a time of 200 min the concentration value is 121 mg/ml. So, a relative large increase of the concentration takes place from the start of the operation. This leads to a high risk of clogging and fouling in the system already at early phases of the filtration.
- Fig. 2 shows a principal schematic view of the filtration system according to the invention.
- two reservoirs are used.
- One small reservoir R2 is integrated in the circuitry in which also the pump P and the filtration module F are integrated.
- the large reservoir R1 is outside the circuitry and is in fluid connection to the circuitry.
- the reservoir R1 has a volume of 15 ml and the reservoir R2 has a volume of 1 ml.
- the minimum recirculation volume of the fluidic circuitry accounts to 100 ⁇ l.
- Fig. 3 shows the theoretical behavior of the concentration over the time in a system according to the invention as shown in Fig. 2 .
- the concentration curve shows a linear increase until a time of 232 min and thereafter an exponential increase. It is shown that the linear increase of the concentration over the time has a sufficiently lower slope than the concentration increase in the state of the art systems with an external reservoir.
- the slope of the linear phase of the concentration increase is dependent on the volume of the fluidic circuitry relative to the permeate flux. Therefore, the slope can be predetermined. In this example at a time of 30 min the concentration is increased from a start concentration of 1 mg/ml to an actual concentration of 2,6 mg/ml.
- the exponential increase starts so that at a time of 248 min the concentration has a value of 125 mg/ml. It is obvious that the low increase at the start phase of the process reduces the risk of a clogging and fouling of the filtration membrane. The advantageous exponential behavior can be shifted in its starting point and starts thereafter. So, the concentration increases very fast after this transition point.
- the further advantage of the filtration system according to the invention is that the minimal working volume is quite low due to the small volume of the reservoir R2 integrated in the circuitry. So, the maximal receivable concentration rate is distinctly higher.
- Fig. 4 shows a preferred embodiment of the flow filtration system 100 according to the invention.
- the system comprises a first reservoir 1 which is located outside a circuitry 3.
- the circuitry 3 comprises a second reservoir 2, a pump module 5, three pressure sensors 6, 7, 8, a pressure regulator 9 and a micro tangential flow filtration module 10.
- the system 100 shown here is a lab scale system in which the reservoir 1 has a volume of 10 to 15 ml.
- the volume of the first reservoir 1 has a volume of 15 ml so that a fluid with a volume of 10 ml can be easily contained in the reservoir 1.
- the first reservoir 1 (reservoir 1) is a discrete element or component like a tank or a container. It is arranged outside the circuitry 3.
- the first reservoir 1 is connected via a connection conduit 31 with the circuitry 3.
- the connection conduit 31 is the only fluid connection between the reservoir 1 and the circuitry 3. It prevents that fluid is flowing from the circuitry 3 back to the reservoir 1.
- the reservoir 1 is directly connected to the reservoir 2 via a direct-line conduit 4 which has the form of a tube or preferably of a pipe.
- the second reservoir 2 (reservoir 2) has a reservoir inlet 11 which can be located at the upper area of the reservoir 2, at one of the side walls or preferably at the bottom of reservoir 2, and a reservoir outlet 12, which is preferably located at the bottom of the reservoir 2 or near the bottom.
- the reservoir inlet 11 and reservoir outlet 12 are connected to the conduits 14 of the circuitry 3.
- a second reservoir inlet 13 is connected to the direct-line conduit 4 so that fluid contained in the reservoir 1 can flow directly into the reservoir 2.
- a valve 17 in the direct-line conduit 4 allows to control the flow of fluid from the first reservoir 1 into the second reservoir 2. Using the valve 17 allows to control the flow from the first fluid reservoir 1 into the circuitry 3.
- the predetermined pressure in the fluidic circuitry can be measured using one or more of the pressure sensors 6, 7 and 8.
- a liquid level sensor 15 installed near the bottom of the reservoir 2 can measure the amount of liquid contained in reservoir 2 so that a control of the fluid level in reservoir 2 can take place.
- Reservoir 2 is preferably a closed reservoir so that the top of the reservoir 2 is sealed with a cap or a lid.
- Reservoir 2 which can have the form of a tank, comprises preferably a vent 16 to allow the removing of gas (e.g. air) from the inside of the reservoir 2.
- the vent 16 can allow air to enter the reservoir 2 in the phase of the processing when the reservoir 1 is depleted and also reservoir 2 starts to be depleted due to a continuous permeate stream through which fluid is withdrawn of the circuitry 3. Further, after depletion of reservoir 1 gas can flow from reservoir 1 to reservoir 2 if valve 17 is open.
- the micro TFF-module 10 comprises a feed inlet 18, a retentate outlet 19, a permeate outlet 20 and a semipermeable membrane 21 capable of separating the fluid sample of the circuitry 3 into a retentate stream and a permeate stream upon passage of the fluid sample into the TFF-module 10 through the inlet feed 18.
- a continuous flow of fluid is driven through the circuitry and the conduits 14 connecting the elements of the circuitry 3 and forming the circuitry 3 together with the integrated elements.
- the conduits 14 are preferably flexible tubings or alternatively rigid pipes or are an integral part of a microstructured module.
- a membrane 21 is used for which the separation time depends on the sample volume and the flux through the membrane.
- the membrane allows a flux of 0.06 ml/min.
- the permeate stream is withdrawn through the permeate outlet 20 so that the withdrawn fluid can be collected in a collection chamber 23.
- the collected fluid amount can easily be measured using a balance 24.
- the pump module 5 comprises two syringes 25 and a valve 26.
- the fluid is circulated in a loop, so that a retentate stream of the TFF-module 10 is recirculated into the second reservoir 2 and to the TFF-module 10 again.
- the flow through the circuitry 3 can also be controlled using the valve 26.
- the pressure sensors 6 and 7 are used to measure a pressure difference. They are preferably located between the pump module 5 and the TFF-module 10. The sensors are located at a non-shown capillary or a channel which has a defined cross sectional area which is different from the cross sectional area of the conduits 14 of the circuitry 3. The difference of the pressure value of the two pressure sensors 6, 7 is used to determine the viscosity of the fluid sample by applying the Hagen-Poiseuille equation.
- the third pressure sensor 8 is located in flow direction behind the filtration module 10. Comparing the measuring values of the pressure sensors 7 and 8 allows to determine the pressure decrease over the filtration module.
- the information of the pressure sensors 6, 7 and 8 can be used to control and monitor the pressure inside the circuitry 3 - and especially the transmembrane pressure which is applied to the membrane 21 - by controlling and adjusting the pressure regulator 9, which is preferably also a valve.
- An outlet valve 27 featuring two ports allows to withdraw fluid from the circuitry and close the circuitry so that a fluid is pumped not through the circuitry 3 but through the outlet port 28 of the outlet valve 27. So, the desired solution with the high concentration of the component can be collected in a result chamber 29 which is connected to the outlet port 28.
- the outlet valve 27 comprises two valves which work together to provide the three-way valve functionality of the output valve 27.
- the circuitry 3 also comprises an optical measuring device for determining the concentration of the components contained in the fluid.
- the optical measuring device comprises preferably a cuvette 30 which allows an online detection of the concentration of the components in the solution. So, the actual concentration of the components can be monitored. The result of the monitoring can be used as a stop criterion to stop the fluid flow in the circuitry 3 and to stop the filtration process as soon as a predetermined concentration rate is reached.
- the cuvette 30 can also be used as a transparent capillary between the pressure sensors 6, 7 for measuring the viscosity. So, the cuvette has the function of a fluid channel or capillary over which length a pressure drop can be detected.
- the fluid system shown in Fig. 4 has a start volume of the fluid contained in the system 100 of 15 ml. 13,9 ml of the start volume are contained in reservoir 1.
- Reservoir 2 contains 1 ml of the volume, the remaining components of the circuitry 3 contains 100 ⁇ l.
- the start concentration is 1 mg/ml. So, the first reservoir 1 has a volume which is at least 10 times larger than the volume of reservoir 2, approximately 15 times larger.
- the second reservoir 2 has a volume of at most 0.7 ml and preferably of at most 0.5 ml. So, the volume of reservoir 1 is more than 20 times larger than the volume of reservoir 2.
- the minimal working volume of the circuitry 3 is decreased. It is preferably at most 1 ml, further preferably at most 700 ⁇ l and also further preferably at most 500 ⁇ l. A minimal working volume of at most 200 ⁇ l is particularly preferably, also a minimal working volume of at most 100 ⁇ l. Due to these minimal working volumes which can be attained with the system 100 according to the invention, a maximum increase factor in concentration of preferably at least 2, further preferably of at least 10, further preferably of at least 20, further preferably 50, further preferably of at least 100 and particularly preferably of at least 150 can be reached.
- the system shown in fig. 4 allows an increase factor in concentration by a factor of at least 100.
Landscapes
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Sampling And Sample Adjustment (AREA)
Claims (17)
- Mikroflussfiltrationssystem, wobei das System (100) einen Flüssigkeitskreislauf (3) und ein erstes Reservoir (1) außerhalb des Kreislaufs (3) aufweist, die zum Aufnehmen einer Flüssigkeit geeignet sind,
wobei der Flüssigkeitskreislauf (3) aufweist:- ein Tangentialfluss-Filtrationsmodul (10) (TFF-Modul) mit einem Zuführungseinlass (18), einem Retentatauslass (19), einem Permeatauslass (20) und einer semipermeablen Membran (21), die die Flüssigkeitsprobe beim Durchgang in das Tangentialfluss-Filtrationsmodul (10) durch den Zuführungseinlass in einen Retentatstrom und einen Permeatstrom aufteilen kann,- ein zweites Reservoir (2), das in den Flüssigkeitskreislauf (3) integriert ist und einen Reservoireinlass (11) und einen Reservoirauslass (12) aufweist, die beide mit dem Kreislauf (3) verbunden sind,- eine Pumpe (5) zum Erzeugen und Antreiben eines Füssigkeitsstroms der Flüssigkeitsprobe durch den Flüssigkeitskreislauf (3) und das Tangentialfluss-Filtrationsmodul (10),- eine Vielzahl von Leitungen (14), die zusammen mit dem zweiten Reservoir (2), dem TFF-Modul (10) und der Pumpe (5) den Flüssigkeitskreislauf bilden, durch den ein Flüssigkeitsstrom der Flüssigkeitsprobe geleitet wird;wobei- das Volumen des äußeren ersten Reservoirs (1) mindestens zweimal so groß ist wie das Volumen des Kreislaufs (3) einschließlich des zweiten Reservoirs (2);- das erste Reservoir (1) außerhalb des Kreislaufs (3) über eine Verbindungsleitung (31) so mit dem Kreislauf (3) verbunden ist, dass die Flüssigkeit unidirektional aus dem ersten Reservoir (1) in den Kreislauf (3) fließt, wobei die Verbindungsleitung (31) einen Rückfluss von Flüssigkeit aus dem Kreislauf (3) in das erste Reservoir (1) verhindert,
wobei das System dadurch gekennzeichnet ist, dass- die Verbindungsleitung (31) eine Länge von mindestens 10 mm hat; und- die Verbindungsleitung (31) einen Durchmesser von höchstens 1 mm hat. - Mikroflussfiltrationssystem nach Anspruch 1, dadurch gekennzeichnet, dass das Volumen des ersten Reservoirs (1) mindestens zehnmal so groß ist wie das Volumen des Kreislaufs (3) einschließlich des zweiten Reservoirs (2), weiter bevorzugt mindestens fünfzigmal so groß, besonders bevorzugt mindestens hundertmal so groß, ebenfalls besonders bevorzugt mindestens tausendmal so groß.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das erste Reservoir (1) und das zweite Reservoir (2) dieselbe Flüssigkeitsprobe enthalten.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das System mindestens einen der Drucksensoren (6, 7, 8), bevorzugt mindestens zwei Drucksensoren (6, 7, 8) umfasst und bevorzugt mindestens ein Drucksensor (6, 7, 8) verwendet wird, um Informationen über den Transmembrandruck und/oder die physikalischen Eigenschaften, bevorzugt die Viskosität, der Flüssigkeitsprobe zu erhalten.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass der Kreislauf (3) eine optische Messvorrichtung (30) zum Erfassen von Informationen über die Konzentration der in der Flüssigkeitsprobe enthaltenen Komponenten umfasst.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das System eine Druckregeleinrichtung (9) zum Regeln des Transmembrandrucks und des Drucks in dem Flüssigkeitskreislauf umfasst.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das erste Reservoir (1) und das zweite Reservoir (2) derart in Fluidverbindung stehen, dass die Flüssigkeitsprobe des ersten Reservoirs (1) direkt in das zweite Reservoir (2) fließt, bevorzugt über eine direkte Verbindungsleitung (4).
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das erste Reservoir (1) ein eigenständiges Element ist, bevorzugt ein Tank oder ein Behälter, und dass das erste Reservoir (1) bevorzugt vom Kreislauf (3) und/oder vom zweiten Reservoir (2) abtrennbar ist.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Verbindungsleitung (31) ein Kapillargefäß oder ein Kapillarkanal oder eine Röhre ist und/oder die Verbindungsleitung (31) eine Länge von mindestens 50 mm, bevorzugt von mindestens 100 mm und besonders bevorzugt von mindestens 200 mm aufweist.
- Mikroflussfiltrationssystem nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Verbindungsleitung (31) einen Durchmesser von höchstens 0,75 mm und bevorzugt von höchstens 0,5 mm aufweist.
- Flussfiltrationsverfahren zum Erhöhen der Konzentration eines in einer Flüssigkeitsprobe enthaltenen Bestandteils mittels eines Tangentialfluss-Filtrationsmoduls (10), wobei das Verfahren die folgenden Schritte umfasst:- Bereitstellen eines Mikroflussfiltrationssystems (100) nach einem der vorhergehenden Ansprüche, umfassend ein erstes Reservoir (1) und einen Flüssigkeitskreislauf (3), wobei das erste Reservoir (1) über eine Verbindungsleitung (31) derart in Verbindung mit dem Kreislauf (3) steht, dass Flüssigkeit unidirektional von dem ersten Reservoir (1) zum Kreislauf fließt, wobei die Verbindungsleitung (31) einen Rückfluss von Flüssigkeit aus dem Kreislauf (3) in das erste Reservoir (1) verhindert und wobei die Konzentration der Flüssigkeit im ersten Reservoir (1) während des gesamten Filtrationsprozesses konstant ist und bleibt und wobei die Verbindungsleitung (31) eine Länge von mindestens 10 mm und einen Durchmesser von höchstens 1mm aufweist, wobei der Kreislauf umfasst:- das Mikrotangentialfluss-Filtrationsmodul (10) mit einem Zuführungseinlass (18), einem Retentatauslass (19) und einem Permeatauslass (20), und eine Membran (21), die die Flüssigkeitsprobe in einen Retentatstrom und einen Permeatstrom aufteilen kann,- ein in den Flüssigkeitskreislauf (3) integriertes zweites Reservoir (2) mit einem Reservoireinlass (11) und einem Reservoirauslass (12), die beide mit dem Kreislauf (3) verbunden sind,- eine Pumpe (5) zum Erzeugen und Antreiben eines Flüssigkeitsstroms der Flüssigkeitsprobe durch den Flüssigkeitskreislauf (3),- eine Vielzahl von Leitungen (14), die zusammen mit dem zweiten Reservoir (2), dem TFF-Modul (10) und der Pumpe (5) den Flüssigkeitskreislauf (3) bilden, durch den ein Flüssigkeitsstrom der Flüssigkeitsprobe geleitet wird,
wobei das Volumen des ersten Reservoirs (1) deutlich größer ist als das Volumen des Kreislaufs (3) einschließlich des zweiten Reservoirs (2),- Befüllen mindestens des ersten Reservoirs (1) mit einer Flüssigkeitsprobe,- Antreiben der Flüssigkeitsprobe durch den Kreislauf (3) und Passieren des TFF-Moduls (10), wodurch die Konzentration der Bestandteile in der Flüssigkeitsprobe im Kreislauf (3) erhöht wird und ein Teil der Flüssigkeit als Permeatstrom entzogen wird,- Herstellen eines Flüssigkeitsstroms von dem ersten Reservoir (1) in den Kreislauf (3) über die Verbindungsleitung (31), der bevorzugt ein kontinuierlicher Strom ist, sodass die dem Kreislauf (3) als Permeatstrom entzogene Flüssigkeitsmenge während des Betriebs des Systems ausgeglichen wird. - Flussfiltrationsverfahren nach Anspruch 11, gekennzeichnet durch Überwachen der Konzentration der Bestandteile in der Flüssigkeitsprobe und/oder der physikalischen Eigenschaften der Flüssigkeitsprobe.
- Flussfiltrationsverfahren nach einem der vorhergehenden Ansprüche 11 bis 12, dadurch gekennzeichnet, dass die Erhöhung der Konzentration der in der Flüssigkeitsprobe enthaltenen Bestandteile ein Faktor von mindestens zwei, bevorzugt von mindestens 10, weiter bevorzugt von mindestens 50, besonders bevorzugt mindestens 100, weiter besonders bevorzugt mindestens 1000 ist.
- Flussfiltrationsverfahren nach einem der vorhergehenden Ansprüche 11 bis 13, dadurch gekennzeichnet, dass die Flüssigkeitsprobe aus dem ersten Reservoir (1) in das zweite Reservoir (2) des Kreislaufs (3) fließt.
- Flussfiltrationsverfahren nach einem der vorhergehenden Ansprüche 11 bis 14, gekennzeichnet durch den folgenden Schritt:
Steuern des Flusses im Kreislauf (3) derart, dass ein vorbestimmter Druck oder ein vorbestimmter Fluss im Kreislauf (3) eingestellt wird. - Flussfiltrationsverfahren nach einem der vorhergehenden Ansprüche 11 bis 15, dadurch gekennzeichnet, dass der Fluss der Flüssigkeit vom ersten Reservoir (1) in den Kreislauf (3) durch eine Drucckraft geregelt wird, bevorzugt durch einen Unterdruck, der bevorzugt von der Pumpe erzeugt wird, oder dass die jeweilige Flüssigkeitsmenge aus dem ersten Reservoir (1) abgesaugt oder ein Druck in dem ersten Reservoir (1) aufgebaut wird, und/oder dass der Fluss derart geregelt wird, dass eine vorgegebene Menge von Probenflüssigkeit im Kreislauf (3) enthalten ist oder dass der Kreislauf (3) vollständig mit Flüssigkeit gefüllt ist, sodass der Kreislauf (3) luftfrei ist.
- Flussfiltrationsverfahren nach einem der vorhergehenden Ansprüche 11 bis 16, dadurch gekennzeichnet, dass der Druck in dem System und/oder der Transmembrandruck durch eine Druckregeleinrichtung geregelt wird.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13712250.3A EP2830744B1 (de) | 2012-03-29 | 2013-03-25 | Mikrofluss-filtrationssystem und flussfiltrationsverfahren |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12162012.4A EP2644259A1 (de) | 2012-03-29 | 2012-03-29 | Mikroflussfiltrationssystem und Flussfiltrationsverfahren |
EP13712250.3A EP2830744B1 (de) | 2012-03-29 | 2013-03-25 | Mikrofluss-filtrationssystem und flussfiltrationsverfahren |
PCT/EP2013/056298 WO2013144091A1 (en) | 2012-03-29 | 2013-03-25 | Micro flow filtration system and flow filtration method |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2830744A1 EP2830744A1 (de) | 2015-02-04 |
EP2830744B1 true EP2830744B1 (de) | 2019-12-18 |
Family
ID=47997503
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12162012.4A Ceased EP2644259A1 (de) | 2012-03-29 | 2012-03-29 | Mikroflussfiltrationssystem und Flussfiltrationsverfahren |
EP13712250.3A Active EP2830744B1 (de) | 2012-03-29 | 2013-03-25 | Mikrofluss-filtrationssystem und flussfiltrationsverfahren |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12162012.4A Ceased EP2644259A1 (de) | 2012-03-29 | 2012-03-29 | Mikroflussfiltrationssystem und Flussfiltrationsverfahren |
Country Status (6)
Country | Link |
---|---|
US (1) | US10213742B2 (de) |
EP (2) | EP2644259A1 (de) |
JP (2) | JP2015515368A (de) |
CN (1) | CN104220149B (de) |
SG (1) | SG11201405934QA (de) |
WO (1) | WO2013144091A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUB20154668A1 (it) * | 2015-10-14 | 2017-04-14 | Mario Goisis | Dispositivo per la filtrazione del grasso estratto con procedure chirurgiche di liposuzione |
CN111770986A (zh) * | 2017-09-27 | 2020-10-13 | 尤尼沃尔塞尔斯股份公司 | 用于制备生物分子(如病毒疫苗)的系统和方法 |
JP6965935B2 (ja) | 2017-09-29 | 2021-11-10 | 日本電気株式会社 | クロスフロー濾過装置、クロスフロー濾過方法 |
EP3466524A1 (de) * | 2017-10-06 | 2019-04-10 | The Automation Partnership (Cambridge) Limited | Multivariate automatisierte querstrom-filtersteuerung |
CN111263631A (zh) * | 2017-10-26 | 2020-06-09 | 瑞普利金公司 | 微型交替切向流灌注过滤器、处理容器及其使用方法 |
US11691107B2 (en) | 2017-11-13 | 2023-07-04 | Emd Millipore Corporation | Continuous diafiltration by means of tank cycling |
JP7319487B2 (ja) * | 2018-01-12 | 2023-08-02 | フォーミュラトリクス・インターナショナル・ホールディング・リミテッド | 接線流ろ過(tff)システム及び一体化ポンプ装置を含む使い捨て可能なtffユニット |
SG11202100317YA (en) * | 2018-07-27 | 2021-02-25 | Univercells Tech S A | System and method for the production of biomolecules |
US20210395664A1 (en) * | 2018-09-21 | 2021-12-23 | Cytiva Sweden Ab | Perfusion Bioprocessing System and Method of Operating the Same |
CN112512667B (zh) * | 2019-03-05 | 2022-12-06 | Arc医疗器械股份有限公司 | 用于粘性组合物的切向流过滤的系统和方法 |
CN112553054A (zh) | 2020-12-10 | 2021-03-26 | 上海艾众生物科技有限公司 | 用于生物反应器的细胞分离设备 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1878487A2 (de) * | 2006-07-13 | 2008-01-16 | Westfalia Separator AG | Verfahren und Vorrichtung zum Verringern oder Verhindern des Zusetzens einer Membran |
US20080023398A1 (en) * | 2006-07-28 | 2008-01-31 | General Electric Company | Method for removal and recovery of water from polymer manufacturing |
FR2940764A1 (fr) * | 2009-01-07 | 2010-07-09 | Benoit Girousse | Adaptation d'un filtre tangentiel a la filtration de produits a fort pouvoir encrassant |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5626503A (en) * | 1979-08-10 | 1981-03-14 | Hitachi Ltd | Removing solid material from liquid |
US4367140A (en) | 1979-11-05 | 1983-01-04 | Sykes Ocean Water Ltd. | Reverse osmosis liquid purification apparatus |
US4747950A (en) * | 1983-12-16 | 1988-05-31 | Cd Medical, Inc. | Method and apparatus for controlled ultrafiltration during hemodialysis |
EP0616836A3 (de) * | 1993-03-23 | 1998-03-04 | Becton, Dickinson and Company | Abtrennungsvorrichtung und -Methode |
US5674394A (en) | 1995-03-24 | 1997-10-07 | Johnson & Johnson Medical, Inc. | Single use system for preparation of autologous plasma |
US5597486A (en) | 1995-05-01 | 1997-01-28 | Millipore Investment Holdings Limited | Membrane filtration with optimized addition of second liquid to maximize flux |
JPH11508813A (ja) | 1995-06-06 | 1999-08-03 | クウォンティック バイオメディカル パートナーズ | 血漿を濃縮するための装置及び方法 |
EP0925494B1 (de) | 1996-09-04 | 2001-12-19 | Scandinavian Micro Biodevices A/S | Mikrofliesssystem für die teilchenanalyse und trennung |
US6406623B2 (en) * | 1997-05-15 | 2002-06-18 | Millipore Corporation | Tangential flow filtration apparatus |
EP0995483A1 (de) * | 1998-10-23 | 2000-04-26 | The Procter & Gamble Company | Querstromfiltrationsvorrichtung |
CA2347375A1 (en) | 1999-08-26 | 2001-03-08 | Bucher-Guyer Ag | Cross-flow filtration method and installation for carrying out said method |
US6607669B2 (en) | 2000-06-23 | 2003-08-19 | Scilog, Inc. | Method and apparatus for enhancing filtration yields in tangential flow filtration |
DE60209131T2 (de) | 2001-10-09 | 2006-09-28 | Millipore Corp., Billerica | Automatisiertes system zur filtration von flüssigkeiten sowie zur erfassung und aufzeichnung von messdaten |
US7270744B2 (en) | 2001-10-09 | 2007-09-18 | Millipore Corporation | Automated low-volume tangential flow filtration process development device |
US6878271B2 (en) | 2002-09-09 | 2005-04-12 | Cytonome, Inc. | Implementation of microfluidic components in a microfluidic system |
US7455770B2 (en) | 2002-09-09 | 2008-11-25 | Cytonome, Inc. | Implementation of microfluidic components in a microfluidic system |
US7291450B2 (en) | 2003-03-28 | 2007-11-06 | Smith & Nephew, Inc. | Preparation of a cell concentrate from a physiological solution |
US7575681B2 (en) | 2004-07-06 | 2009-08-18 | Schlumberger Technology Corporation | Microfluidic separator |
US7955504B1 (en) | 2004-10-06 | 2011-06-07 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Microfluidic devices, particularly filtration devices comprising polymeric membranes, and method for their manufacture and use |
US20090101559A1 (en) | 2005-01-21 | 2009-04-23 | Anand Bala Subramaniam | Microconcentrator/Microfilter |
US8574432B2 (en) | 2005-04-14 | 2013-11-05 | California Institute Of Technology | Integrated chromatography devices and systems for monitoring analytes in real time and methods for manufacturing the same |
US7872225B2 (en) | 2006-08-25 | 2011-01-18 | Perkinelmer Health Sciences, Inc. | Sample component trapping, release, and separation with membrane assemblies interfaced to electrospray mass spectrometry |
US7384549B2 (en) | 2005-12-29 | 2008-06-10 | Spf Innovations, Llc | Method and apparatus for the filtration of biological solutions |
GB0606144D0 (en) * | 2006-03-28 | 2006-05-10 | Ge Healthcare Bio Sciences Ab | Automated crossflow filtration method and system |
JP2008183470A (ja) | 2007-01-26 | 2008-08-14 | Daicen Membrane Systems Ltd | エマルション水溶液の濾過装置 |
JP2009221137A (ja) | 2008-03-14 | 2009-10-01 | Asahi Kasei Corp | 限外濾過膜を用いた生体成分の分離方法およびモジュール、装置 |
-
2012
- 2012-03-29 EP EP12162012.4A patent/EP2644259A1/de not_active Ceased
-
2013
- 2013-03-25 CN CN201380017309.5A patent/CN104220149B/zh not_active Expired - Fee Related
- 2013-03-25 SG SG11201405934QA patent/SG11201405934QA/en unknown
- 2013-03-25 US US14/386,097 patent/US10213742B2/en not_active Expired - Fee Related
- 2013-03-25 EP EP13712250.3A patent/EP2830744B1/de active Active
- 2013-03-25 JP JP2015502281A patent/JP2015515368A/ja active Pending
- 2013-03-25 WO PCT/EP2013/056298 patent/WO2013144091A1/en active Application Filing
-
2017
- 2017-06-06 JP JP2017111768A patent/JP6683653B2/ja not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1878487A2 (de) * | 2006-07-13 | 2008-01-16 | Westfalia Separator AG | Verfahren und Vorrichtung zum Verringern oder Verhindern des Zusetzens einer Membran |
US20080023398A1 (en) * | 2006-07-28 | 2008-01-31 | General Electric Company | Method for removal and recovery of water from polymer manufacturing |
FR2940764A1 (fr) * | 2009-01-07 | 2010-07-09 | Benoit Girousse | Adaptation d'un filtre tangentiel a la filtration de produits a fort pouvoir encrassant |
Also Published As
Publication number | Publication date |
---|---|
WO2013144091A1 (en) | 2013-10-03 |
US20150041395A1 (en) | 2015-02-12 |
SG11201405934QA (en) | 2014-10-30 |
CN104220149B (zh) | 2016-08-24 |
JP2015515368A (ja) | 2015-05-28 |
CN104220149A (zh) | 2014-12-17 |
JP6683653B2 (ja) | 2020-04-22 |
EP2644259A1 (de) | 2013-10-02 |
JP2017205760A (ja) | 2017-11-24 |
EP2830744A1 (de) | 2015-02-04 |
US10213742B2 (en) | 2019-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2830744B1 (de) | Mikrofluss-filtrationssystem und flussfiltrationsverfahren | |
US11110398B2 (en) | Method for enhancing filtration yields in tangential flow filtration system | |
US8231787B2 (en) | Tangential flow filtration system | |
US11045767B2 (en) | Micro flow filtration system and integrated microfluidic element | |
EP2830743B1 (de) | Mikroflussfiltrationssystem und flussfiltrationsverfahren für eine flüssigkeitsprobe | |
KR102285176B1 (ko) | 단백질 용액으로부터의 연속식 완충제 또는 배지 교환을 위한 한외여과 장치 | |
AU2020212005B2 (en) | Methods and apparatus to selectively extract constituents from biological samples | |
Lüken et al. | Automated tangential-flow diafiltration device | |
EP3374071B1 (de) | Mischverfahren und -system | |
JP2020079713A (ja) | 分析装置及び該分析装置に用いられる濃縮装置 | |
US20220212125A1 (en) | Method for degassing a cross-flow diafiltration unit, cross-flow diafiltration method and cross-flow diafiltration unit | |
EP3851827B1 (de) | Filtrationsmodul und anordnung zum filtern eines prozessmediums in einem bioprozess und verfahren zur probenentnahme während eines bioprozesses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141023 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: F.HOFFMANN-LA ROCHE AG |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20181126 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20190619 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAR | Information related to intention to grant a patent recorded |
Free format text: ORIGINAL CODE: EPIDOSNIGR71 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
INTC | Intention to grant announced (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GROSSMANN, ADELBERT Inventor name: LOSLEBEN, NADINE Inventor name: ORANTH, NORBERT Inventor name: LUTZ, SASCHA |
|
INTG | Intention to grant announced |
Effective date: 20191106 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013064069 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1213973 Country of ref document: AT Kind code of ref document: T Effective date: 20200115 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20191218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200318 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200319 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200318 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200513 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200418 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013064069 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1213973 Country of ref document: AT Kind code of ref document: T Effective date: 20191218 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
26N | No opposition filed |
Effective date: 20200921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200331 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220223 Year of fee payment: 10 Ref country code: DE Payment date: 20220210 Year of fee payment: 10 Ref country code: CH Payment date: 20220210 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20220218 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191218 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602013064069 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230325 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230331 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230325 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230331 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231003 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230331 |